Predicting Rehabilitation Outcomes in Bilingual Aphasia Using Computational Modeling (PROCoM)

April 13, 2021 updated by: Swathi Kiran, Boston University Charles River Campus

Double-blind Randomized Trial Investigating the Use of Computational Modeling to Predict Rehabilitation Outcomes in Bilingual Aphasia

The purpose of this investigation is to implement a computational model that can predict and optimize training and cross-language generalization patterns for bilingual persons with aphasia (BPA). The proposed work will determine the best possible treatment program for each individual patient even before they are rehabilitated. In addition, the computational model allows specification of variables such as age of acquisition, language exposure/proficiency, impairment and their systematic influence on a range of language rehabilitation outcomes.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Nishaat Mukadam, MA
  • Phone Number: 617-353-2706
  • Email: mukadamn@bu.edu

Study Locations

    • California
      • San Francisco, California, United States, 94132
        • Recruiting
        • San Francisco State University
        • Contact:
    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Recruiting
        • Boston University Sargent College
        • Contact:
        • Contact:
          • Swathi Kiran, PhD
          • Phone Number: 617-358-5478
          • Email: kirans@bu.edu
        • Principal Investigator:
          • Swathi Kiran, PhD
    • Texas
      • Austin, Texas, United States, 78757

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Any number of years of education
  • Bilingual: speaking both Spanish and English (or Chinese and English) with any degree of language proficiency prior to stroke
  • Aphasia secondary to a left-hemisphere stroke (diagnosed by a neurologist on the basis of clinical CT/MRI imaging or medical reports)
  • Aphasia resulting from stroke or dementia
  • Naming deficits must be present with concurrent lexical/semantic impairment
  • Visual and auditory acuity sufficient for all assessment and treatment procedures
  • Ability to understand study and follow study procedures for the entire length of the study

Exclusion Criteria:

  • Premorbid history of speech/language disorder
  • Proficient in more than just Spanish and English (or Chinese and English)
  • Overt, behaviorally noticeable, attentional limitations that interfere with completing the experimental tasks
  • Active medical disease that may compromise participation (e.g., cancer undergoing acute treatment, unstable diabetes, renal or hepatic insufficiency, fluctuating systemic immunological disease such as systemic lupus erythematosis, etc.)
  • Currently taking medications that are known to exert significant effects on cognitive processes, such as neuroleptics, steroids, anticholinesterase inhibitors, etc.
  • Current drug or alcohol use or dependence that would interfere with adherence to study requirements, in the opinion of the principal investigator
  • Inability or unwillingness of individual to give written informed consent
  • Diagnosed with mental illness other than active depression
  • Neurological condition other than that which resulted in aphasia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Model-based
Semantic Feature Analysis training will be provided in the language that was selected by the computational model.
SFA training entails having the speech-language pathologist (SLP) guide the participant through generation of pertinent semantic features for pictured treatment items (e.g., category membership, physical description, location of item in context, action associated with item). Treatment is applied to a set of items in the context of single-subject, multiple baseline designs so that replication of treatment effects could be evaluated within and across participants. Treatment will be administered two times per week until prescribed accuracy levels were met during treatment probes or a maximum number of treatment sessions was completed.
Active Comparator: Model-opposite
Semantic Feature Analysis training will be provided in the language opposite to that which was selected by the computational model.
SFA training entails having the speech-language pathologist (SLP) guide the participant through generation of pertinent semantic features for pictured treatment items (e.g., category membership, physical description, location of item in context, action associated with item). Treatment is applied to a set of items in the context of single-subject, multiple baseline designs so that replication of treatment effects could be evaluated within and across participants. Treatment will be administered two times per week until prescribed accuracy levels were met during treatment probes or a maximum number of treatment sessions was completed.
No Intervention: Sub-Study: Computational Modeling for Bilingual Dementia and Semantic Decline
This is a sub-study aimed at building a computational model to simulate bilingual dementia and semantic decline.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Word Retrieval Accuracy in both languages
Time Frame: Through study completion, an average of 10 weeks
Accuracy of naming of pictured treated and untreated items in both languages will be assessed in probes conducted separate from treatment. Probes were conducted repeatedly throughout the study, from baseline (prior to treatment) to the end of treatment. All naming responses were scored using as correct or incorrect. A percentage accuracy was calculated for each set of items for every probe session. Baseline probe scores were compared to end of treatment probe scores to obtain individual effect sizes for each sets of items for each participant (i.e., several effect sizes were calculated for each participant).
Through study completion, an average of 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psycholinguistic assessments of language processing in aphasia (PALPA) in both languages
Time Frame: Week 1 and up to 10 weeks
Reading single words and understanding spoken words
Week 1 and up to 10 weeks
Boston Naming Test (BNT) in both languages
Time Frame: Week 1 and up to 10 weeks
Naming pictured items
Week 1 and up to 10 weeks
Bilingual Aphasia Test (BAT) B and C in both languages
Time Frame: Week 1 and up to 10 weeks
Assesses each of the languages of a bilingual or multilingual individual with aphasia
Week 1 and up to 10 weeks
Western Aphasia Battery (WAB) in both languages
Time Frame: Week 1 and up to 10 weeks
Assesses the levels of impairment of aphasia
Week 1 and up to 10 weeks
Cognitive Linguistic Quick Test (CLQT) in both languages
Time Frame: Week 1 and up to 10 weeks
Assesses the contribution of cognitive deficits to language dysfunction
Week 1 and up to 10 weeks
Verbal fluency task (COWAT) in both languages
Time Frame: Week 1 and up to 10 weeks
Assesses general fluency
Week 1 and up to 10 weeks
Category fluency task in both languages
Time Frame: Week 1 and up to 10 weeks
Assesses category fluency
Week 1 and up to 10 weeks
Communication Effectiveness Index (CETI) for both languages
Time Frame: Week 1 and up to 10 weeks
Determines communication effectiveness by proxy
Week 1 and up to 10 weeks
Pyramids and Palm Trees Test (PAPT) 3 pictures version
Time Frame: Week 1 and up to 10 weeks
Assesses semantic processing ability
Week 1 and up to 10 weeks
Aphasia Bank
Time Frame: Week 1 and up to 10 weeks
Assesses discourse
Week 1 and up to 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Swathi Kiran, PhD, Boston University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2018

Primary Completion (Anticipated)

July 31, 2021

Study Completion (Anticipated)

July 31, 2023

Study Registration Dates

First Submitted

September 16, 2016

First Submitted That Met QC Criteria

September 26, 2016

First Posted (Estimate)

September 27, 2016

Study Record Updates

Last Update Posted (Actual)

April 19, 2021

Last Update Submitted That Met QC Criteria

April 13, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe